Do analysts prefer ELVA or ULBI?

Electrovaya presently has a consensus price target of $17.50, indicating a potential upside of 167.18%. Given Electrovaya's stronger consensus rating and higher possible upside, equities analysts clearly believe Electrovaya is more favorable than Ultralife. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Electrovaya 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.83 Ultralife 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media prefer ELVA or ULBI?

In the previous week, Electrovaya had 1 more articles in the media than Ultralife. MarketBeat recorded 3 mentions for Electrovaya and 2 mentions for Ultralife. Ultralife's average media sentiment score of 1.92 beat Electrovaya's score of 0.47 indicating that Ultralife is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Electrovaya 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Ultralife 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts rate ABAT or ULBI?

American Battery Technology currently has a consensus target price of $6.00, indicating a potential upside of 130.77%. Given American Battery Technology's stronger consensus rating and higher possible upside, analysts clearly believe American Battery Technology is more favorable than Ultralife. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score American Battery Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50 Ultralife 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media prefer ABAT or ULBI?

In the previous week, American Battery Technology had 2 more articles in the media than Ultralife. MarketBeat recorded 4 mentions for American Battery Technology and 2 mentions for Ultralife. Ultralife's average media sentiment score of 1.92 beat American Battery Technology's score of 0.92 indicating that Ultralife is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment American Battery Technology 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Ultralife 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts prefer MVST or ULBI?

Microvast presently has a consensus price target of $4.00, indicating a potential upside of 421.85%. Given Microvast's stronger consensus rating and higher probable upside, equities analysts plainly believe Microvast is more favorable than Ultralife. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Microvast 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Ultralife 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is MVST or ULBI more profitable?

Microvast has a net margin of 13.95% compared to Ultralife's net margin of -3.50%. Ultralife's return on equity of 2.75% beat Microvast's return on equity. Company Net Margins Return on Equity Return on Assets Microvast 13.95% -10.34% -4.64% Ultralife -3.50% 2.75% 1.66%

Does the media prefer MVST or ULBI?

In the previous week, Microvast had 23 more articles in the media than Ultralife. MarketBeat recorded 25 mentions for Microvast and 2 mentions for Ultralife. Ultralife's average media sentiment score of 1.92 beat Microvast's score of 0.13 indicating that Ultralife is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Microvast 2 Very Positive mention(s) 0 Positive mention(s) 22 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Ultralife 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts prefer ULBI or SES?

SES AI has a consensus target price of $2.55, suggesting a potential upside of 373.01%. Given SES AI's stronger consensus rating and higher probable upside, analysts clearly believe SES AI is more favorable than Ultralife. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ultralife 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SES AI 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better earnings & valuation, ULBI or SES?

Ultralife has higher revenue and earnings than SES AI. Ultralife is trading at a lower price-to-earnings ratio than SES AI, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ultralife $191.16M 0.57 -$5.90M -$0.40 N/A SES AI $21M 9.53 -$73.04M -$0.20 N/A

Is ULBI or SES more profitable?

Ultralife has a net margin of -3.50% compared to SES AI's net margin of -289.64%. Ultralife's return on equity of 2.75% beat SES AI's return on equity. Company Net Margins Return on Equity Return on Assets Ultralife -3.50% 2.75% 1.66% SES AI -289.64% -26.21% -20.78%

Do analysts recommend ULBI or EAF?

GrafTech International has a consensus target price of $10.67, indicating a potential upside of 52.82%. Given GrafTech International's stronger consensus rating and higher probable upside, analysts plainly believe GrafTech International is more favorable than Ultralife. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ultralife 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 GrafTech International 3 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Ultralife (ULBI) Competitors

$6.56 -0.03 (-0.46%)

As of 08/26/2026 04:00 PM Eastern

Compare

ULBI vs. ELVA, ABAT, MVST, SES, and EAF

Should you buy Ultralife stock or one of its competitors? Ultralife's main competitors and comparable companies include Electrovaya (ELVA), American Battery Technology (ABAT), Microvast (MVST), SES AI (SES), and GrafTech International (EAF). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "electrical components & equipment" industry.

How does Ultralife compare to Electrovaya?

Electrovaya (NASDAQ:ELVA) and Ultralife (NASDAQ:ULBI) are both small-cap industrials companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, profitability, dividends, risk, media sentiment and institutional ownership.

Electrovaya presently has a consensus price target of $17.50, indicating a potential upside of 167.18%. Given Electrovaya's stronger consensus rating and higher possible upside, equities analysts clearly believe Electrovaya is more favorable than Ultralife.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Electrovaya	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.83
Ultralife	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Electrovaya has higher earnings, but lower revenue than Ultralife. Ultralife is trading at a lower price-to-earnings ratio than Electrovaya, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Electrovaya	$71.57M	4.53	$3.36M	$0.11	59.55
Ultralife	$191.16M	0.57	-$5.90M	-$0.40	N/A

Electrovaya has a beta of 1.69, meaning that its share price is 69% more volatile than the broader market. Comparatively, Ultralife has a beta of 0.8, meaning that its share price is 20% less volatile than the broader market.

22.5% of Electrovaya shares are held by institutional investors. Comparatively, 30.7% of Ultralife shares are held by institutional investors. 42.9% of Ultralife shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Electrovaya had 1 more articles in the media than Ultralife. MarketBeat recorded 3 mentions for Electrovaya and 2 mentions for Ultralife. Ultralife's average media sentiment score of 1.92 beat Electrovaya's score of 0.47 indicating that Ultralife is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Electrovaya	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Ultralife	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Electrovaya has a net margin of 6.14% compared to Ultralife's net margin of -3.50%. Electrovaya's return on equity of 7.96% beat Ultralife's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Electrovaya	6.14%	7.96%	4.54%
Ultralife	-3.50%	2.75%	1.66%

Summary

Electrovaya beats Ultralife on 13 of the 17 factors compared between the two stocks.

How does Ultralife compare to American Battery Technology?

American Battery Technology (NASDAQ:ABAT) and Ultralife (NASDAQ:ULBI) are both small-cap industrials companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, earnings, risk, dividends, media sentiment, valuation, analyst recommendations and profitability.

Ultralife has higher revenue and earnings than American Battery Technology. Ultralife is trading at a lower price-to-earnings ratio than American Battery Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
American Battery Technology	$4.29M	82.67	-$46.76M	-$0.52	N/A
Ultralife	$191.16M	0.57	-$5.90M	-$0.40	N/A

American Battery Technology currently has a consensus target price of $6.00, indicating a potential upside of 130.77%. Given American Battery Technology's stronger consensus rating and higher possible upside, analysts clearly believe American Battery Technology is more favorable than Ultralife.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
American Battery Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
Ultralife	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, American Battery Technology had 2 more articles in the media than Ultralife. MarketBeat recorded 4 mentions for American Battery Technology and 2 mentions for Ultralife. Ultralife's average media sentiment score of 1.92 beat American Battery Technology's score of 0.92 indicating that Ultralife is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
American Battery Technology	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Ultralife	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

American Battery Technology has a beta of 0.27, suggesting that its stock price is 73% less volatile than the broader market. Comparatively, Ultralife has a beta of 0.8, suggesting that its stock price is 20% less volatile than the broader market.

Ultralife has a net margin of -3.50% compared to American Battery Technology's net margin of -390.48%. Ultralife's return on equity of 2.75% beat American Battery Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
American Battery Technology	-390.48%	-63.85%	-59.33%
Ultralife	-3.50%	2.75%	1.66%

9.9% of American Battery Technology shares are held by institutional investors. Comparatively, 30.7% of Ultralife shares are held by institutional investors. 2.8% of American Battery Technology shares are held by insiders. Comparatively, 42.9% of Ultralife shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Ultralife beats American Battery Technology on 10 of the 16 factors compared between the two stocks.

How does Ultralife compare to Microvast?

Microvast (NASDAQ:MVST) and Ultralife (NASDAQ:ULBI) are both small-cap industrials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, media sentiment, analyst recommendations, earnings and valuation.

Microvast has a beta of 3.55, meaning that its stock price is 255% more volatile than the broader market. Comparatively, Ultralife has a beta of 0.8, meaning that its stock price is 20% less volatile than the broader market.

In the previous week, Microvast had 23 more articles in the media than Ultralife. MarketBeat recorded 25 mentions for Microvast and 2 mentions for Ultralife. Ultralife's average media sentiment score of 1.92 beat Microvast's score of 0.13 indicating that Ultralife is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Microvast	2 Very Positive mention(s)	0 Positive mention(s)	22 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Ultralife	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Microvast has a net margin of 13.95% compared to Ultralife's net margin of -3.50%. Ultralife's return on equity of 2.75% beat Microvast's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Microvast	13.95%	-10.34%	-4.64%
Ultralife	-3.50%	2.75%	1.66%

20.7% of Microvast shares are owned by institutional investors. Comparatively, 30.7% of Ultralife shares are owned by institutional investors. 44.8% of Microvast shares are owned by insiders. Comparatively, 42.9% of Ultralife shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Microvast presently has a consensus price target of $4.00, indicating a potential upside of 421.85%. Given Microvast's stronger consensus rating and higher probable upside, equities analysts plainly believe Microvast is more favorable than Ultralife.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Microvast	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Ultralife	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Ultralife has lower revenue, but higher earnings than Microvast. Microvast is trading at a lower price-to-earnings ratio than Ultralife, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Microvast	$427.52M	0.69	-$29.22M	-$0.02	N/A
Ultralife	$191.16M	0.57	-$5.90M	-$0.40	N/A

Summary

Microvast beats Ultralife on 10 of the 16 factors compared between the two stocks.

How does Ultralife compare to SES AI?

Ultralife (NASDAQ:ULBI) and SES AI (NYSE:SES) are both small-cap industrials companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, analyst recommendations, profitability, dividends and earnings.

SES AI has a consensus target price of $2.55, suggesting a potential upside of 373.01%. Given SES AI's stronger consensus rating and higher probable upside, analysts clearly believe SES AI is more favorable than Ultralife.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ultralife	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
SES AI	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

30.7% of Ultralife shares are held by institutional investors. Comparatively, 29.8% of SES AI shares are held by institutional investors. 42.9% of Ultralife shares are held by company insiders. Comparatively, 13.8% of SES AI shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Ultralife has a net margin of -3.50% compared to SES AI's net margin of -289.64%. Ultralife's return on equity of 2.75% beat SES AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ultralife	-3.50%	2.75%	1.66%
SES AI	-289.64%	-26.21%	-20.78%

Ultralife has a beta of 0.8, suggesting that its share price is 20% less volatile than the broader market. Comparatively, SES AI has a beta of 1.01, suggesting that its share price is 1% more volatile than the broader market.

Ultralife has higher revenue and earnings than SES AI. Ultralife is trading at a lower price-to-earnings ratio than SES AI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ultralife	$191.16M	0.57	-$5.90M	-$0.40	N/A
SES AI	$21M	9.53	-$73.04M	-$0.20	N/A

In the previous week, Ultralife had 2 more articles in the media than SES AI. MarketBeat recorded 2 mentions for Ultralife and 0 mentions for SES AI. Ultralife's average media sentiment score of 1.92 beat SES AI's score of 0.00 indicating that Ultralife is being referred to more favorably in the media.

Company	Overall Sentiment
Ultralife	Very Positive
SES AI	Neutral

Summary

Ultralife beats SES AI on 9 of the 16 factors compared between the two stocks.

How does Ultralife compare to GrafTech International?

Ultralife (NASDAQ:ULBI) and GrafTech International (NYSE:EAF) are both small-cap industrials companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, dividends, risk, institutional ownership, profitability, analyst recommendations, valuation and media sentiment.

GrafTech International has a consensus target price of $10.67, indicating a potential upside of 52.82%. Given GrafTech International's stronger consensus rating and higher probable upside, analysts plainly believe GrafTech International is more favorable than Ultralife.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ultralife	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
GrafTech International	3 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Ultralife has higher earnings, but lower revenue than GrafTech International. Ultralife is trading at a lower price-to-earnings ratio than GrafTech International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ultralife	$191.16M	0.57	-$5.90M	-$0.40	N/A
GrafTech International	$512.92M	0.36	-$219.84M	-$6.80	N/A

In the previous week, Ultralife had 2 more articles in the media than GrafTech International. MarketBeat recorded 2 mentions for Ultralife and 0 mentions for GrafTech International. Ultralife's average media sentiment score of 1.92 beat GrafTech International's score of 0.00 indicating that Ultralife is being referred to more favorably in the media.

Company	Overall Sentiment
Ultralife	Very Positive
GrafTech International	Neutral

30.7% of Ultralife shares are owned by institutional investors. Comparatively, 92.8% of GrafTech International shares are owned by institutional investors. 42.9% of Ultralife shares are owned by company insiders. Comparatively, 1.2% of GrafTech International shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Ultralife has a beta of 0.8, indicating that its stock price is 20% less volatile than the broader market. Comparatively, GrafTech International has a beta of 1.83, indicating that its stock price is 83% more volatile than the broader market.

Ultralife has a net margin of -3.50% compared to GrafTech International's net margin of -34.58%. Ultralife's return on equity of 2.75% beat GrafTech International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ultralife	-3.50%	2.75%	1.66%
GrafTech International	-34.58%	N/A	-17.50%

Summary

Ultralife beats GrafTech International on 9 of the 15 factors compared between the two stocks.

Get Ultralife News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ULBI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ULBI vs. The Competition

Export

Metric	Ultralife	Electrical Equipment Industry	Industrials Sector	NASDAQ Exchange
Market Cap	$109.81M	$10.42B	$10.65B	$12.81B
Dividend Yield	N/A	2.33%	97.24%	11.02%
P/E Ratio	-16.40	45.12	26.56	24.11
Price / Sales	0.57	1,685.37	364.93	93.89
Price / Cash	10.95	30.18	24.47	53.65
Price / Book	0.82	6.18	4.48	6.20
Net Income	-$5.90M	$139.36M	$611.08M	$348.07M
7 Day Performance	-4.23%	0.59%	0.21%	1.11%
1 Month Performance	21.26%	1.05%	1.97%	4.27%
1 Year Performance	-4.93%	15.03%	10.82%	16.48%

Ultralife Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ULBI Ultralife	1.21 of 5 stars	$6.56 -0.5%	N/A	-5.6%	$109.81M	$191.16M	N/A	560
ELVA Electrovaya	2.8765 of 5 stars	$7.50 -2.6%	$17.50 +133.3%	+19.5%	$393.58M	$63.83M	68.19	97
ABAT American Battery Technology	2.2321 of 5 stars	$2.35 -3.3%	$6.00 +155.3%	-5.5%	$339.67M	$4.29M	N/A	54
MVST Microvast	3.1632 of 5 stars	$0.76 -5.7%	$4.00 +425.3%	-71.8%	$310.47M	$367.56M	N/A	1,908	Trending News
SES SES AI	1.9662 of 5 stars	$0.54 -5.8%	$2.55 +375.7%	-51.2%	$220.34M	$21M	N/A	130

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ULBI) was last updated on 8/27/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ultralife (ULBI) Competitors

ULBI vs. ELVA, ABAT, MVST, SES, and EAF

How does Ultralife compare to Electrovaya?

Summary

How does Ultralife compare to American Battery Technology?

Summary

How does Ultralife compare to Microvast?

Summary

How does Ultralife compare to SES AI?

Summary

How does Ultralife compare to GrafTech International?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ULBI vs. The Competition

Ultralife Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ultralife (ULBI) Competitors

ULBI vs. ELVA, ABAT, MVST, SES, and EAF

How does Ultralife compare to Electrovaya?

Do analysts prefer ELVA or ULBI?

Which has stronger earnings and valuation, ELVA or ULBI?

Which has more volatility & risk, ELVA or ULBI?

Do insiders & institutionals have more ownership in ELVA or ULBI?

Does the media prefer ELVA or ULBI?

Is ELVA or ULBI more profitable?

Summary

How does Ultralife compare to American Battery Technology?

Which has higher valuation & earnings, ABAT or ULBI?

Do analysts rate ABAT or ULBI?

Does the media prefer ABAT or ULBI?

Which has more volatility and risk, ABAT or ULBI?

Is ABAT or ULBI more profitable?

Do insiders & institutionals have more ownership in ABAT or ULBI?

Summary

How does Ultralife compare to Microvast?

Which has more risk & volatility, MVST or ULBI?

Does the media prefer MVST or ULBI?

Is MVST or ULBI more profitable?

Do institutionals & insiders believe in MVST or ULBI?

Do analysts prefer MVST or ULBI?

Which has stronger valuation & earnings, MVST or ULBI?

Summary

How does Ultralife compare to SES AI?

Do analysts prefer ULBI or SES?

Do insiders & institutionals believe in ULBI or SES?

Is ULBI or SES more profitable?

Which has more risk & volatility, ULBI or SES?

Which has better earnings & valuation, ULBI or SES?

Does the media refer more to ULBI or SES?

Summary

How does Ultralife compare to GrafTech International?

Do analysts recommend ULBI or EAF?

Which has stronger earnings and valuation, ULBI or EAF?

Does the media favor ULBI or EAF?

Do insiders and institutionals believe in ULBI or EAF?

Which has more risk & volatility, ULBI or EAF?

Is ULBI or EAF more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ULBI vs. The Competition

Ultralife Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools